Industry News
Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.
- Written by Editor-in-Chief
- Category: Industry News
Electric and magnetic fields (EMF) generated from everyday household appliances, electrical tools and more, used in very close proximity to the body, can interfere with the ability of pacemakers to regulate patients’ heartbeats, according to new research in the American Heart Association’s journal Circulation. “Electromagnetic interferences with pacemakers in everyday life can occur; however, harmful interferences are rare using vendors’ recommended device settings,” said medical doctor Andreas Napp, study author and cardiologist at RWTH Aachen University Hospital in Aachen, Germany. “Dedicated device programming is an effective measure to reduce the individual risk of interference. For example, doctors can reprogramme pacemakers to a lower sensitivity to reduce EMF susceptibility.
- Written by Editor-in-Chief
- Category: Industry News
A woman, known as 'Katt', has put her used breast implants for sale on eBay - insisting they are in 'excellent condition' despite being inside her body for 11 months A woman has put her used breast implants for sale on eBay - insisting they are in 'excellent condition' despite being inside her body for 11 months.
- Written by Editor-in-Chief
- Category: Industry News
InDX, a new thumb implant from Galway-based medical devices start-up Loci Orthopaedics, has the potential to completely disrupt how painful thumb joint arthritis is treated, according to its founders Dr Brendan Boland and engineer Gerry Clarke. “The thumb base joint is one of the most remarkably complex but beautifully elegant joints in the body, but when a problem develops, the current treatment options are not great,” Boland says. “Some surgeons take out a bone. Others fuse the joint. Joint implants similar to those used in hip arthritis are also used but they have an unacceptably high failure rate because of the complexity of the joint.
- Written by Editor-in-Chief
- Category: Industry News
Neil King Saturday 04 March 2017 At the end of January, more than 4,400 healthcare companies from 70 countries across the world gathered at Arab Health in Dubai – the annual regional showcase of the industry’s latest technologies, trends, workshops and discussions. Among the many and varied developments and topics at the exhibition were big data, orthopaedics, oncology, radiology, workforce empowerment and diabetes.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five points: 1. B. Riley researchers estimate Mazor will see second quarter 2018 earnings of $0.13 EPS; third quarter 2018 earnings of $0.12 EPS; and fourth quarter 2018 earnings of $0.07 EPS. 2. The firm has a "neutral" rating on Mazor with a $25 price objective. 3. Mazor has a 52-week low of $9.16 and 52-week high of $26.55. 4. The company's 50-day moving average is $22.62, with a 200-day moving average of $22.74.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are four insights: 1. The increasing importance of data-driven information is attracting the emergence of technology giants. 2. The larger technology organizations offer their experience in dealing with information issues in other industries. 3. Industry experts foresee consolidation activity as more HIT startups enter the scene. Where smaller companies can zone in on a trend, larger companies can provide the customer base. 4. Technology companies will reap benefits by focusing on user experience, from reducing wait times to ensuring privacy.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five key notes: 1. The 4D Health Approach is holistic and takes into consideration a patient's overall health, ailments, environment and future aspirations. 2. Specifically, the approach addresses nutrition, exercise and supplementation to shorten recovery, improve wound healing and enhance strength following surgery. 3. Dr. Lanman uses the Prestige LP artificial disc, composed of titanium-ceramic composite, for disc replacement procedures. 4. Dr. Lanman served as the principal investigator on the FDA trial testing the Prestige LP disc, which was approved for one or two adjacent levels in the cervical spine in 2016.
- Written by Editor-in-Chief
- Category: Industry News
Transparency Market Research Report Added "Regenerative Medicine Market" to its database.Albany, NY -- (SBWIRE) -- 03/03/2017 -- Regenerative medicine is an emerging field in the healthcare industry concerned with the repair, replacement, and regeneration of damaged human tissue and organs. This includes damage from age-related degeneration, congenital defects, accidents, or diseases. Due to its vital contribution, regenerative medicine is becoming widely popular in the treatment of neurological, cardiovascular, musculoskeletal, and orthopedic conditions. Bone and joint conditions are among the leading applications of regenerative medicine. The viability of several synthetic alternatives to bones and joints is one of the key points that have driven investment in regenerative medicine in the recent past.
- Written by Editor-in-Chief
- Category: Industry News
The U.S. Food and Drug Administration (FDA) has announced a Class I recall of the Zimmer Biomet Comprehensive Reverse Shoulder device.
- Written by Editor-in-Chief
- Category: Industry News
NEW DELHI: Hospitals, nursing homes and clinics that implant cardiac stents cannot claim margins on the life-saving devices, says the government. The decision is expected to break the nexus between manufacturers, doctors and hospitals that have led to "unethical" markups in the prices of these stents. A cardiac stent is a wire mesh tube used to clear blockages in coronary arteries and prevent heart attacks. The National Pharmaceutical Pricing Authority on February 14 slashed stent prices by over 75%. Including VAT, drug eluting stents (DES) and bioresorbable vascular scaffolds (BVS) will now only cost heart patients Rs 31,080, while bare metal stents (BMS) would cost Rs 7,623.
Submit Community Content
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!